Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317268523> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2317268523 endingPage "82" @default.
- W2317268523 startingPage "72" @default.
- W2317268523 abstract "Abnormal dopamine neurotransmission has been linked to a wide array of motor, cognitive, and psychiatric disorders. Dopamine binds and regulates intracellular signals through D1-like (D1 and D5) and D2-like (D2, D3, and D4) G-protein coupled receptors. Activation of D1- like receptors stimulates cAMP/PKA signaling via Gs mediated activation of adenylyl cyclase. In contrast, activation of D2-like receptors inhibits cAMP/PKA signaling by Gi inhibition of adenylyl cyclase. In the brain, dopamine signaling is tightly regulated by cyclic nucleotide phosphodiesterases (PDEs). PDEs are a family of enzymes that selectively degrade cAMP and cGMP. There are 11 different families of PDEs that vary in their substrate specificity, kinetic properties, mode of regulation, intracellular localization, and tissue expression patterns. A number of PDE families are highly expressed in the striatum including PDE1, PDE2, PDE4, and PDE10. There is a growing amount of evidence to suggest that these enzymes play a critical role in modulating dopamine signaling and selective inhibitors of these enzymes are currently being explored as novel therapeutics to treat schizophrenia, Huntington's disease, cognitive disorders and Parkinson's disease. The aim of this review is to summarize the distinct roles of different PDEs in regulating dopamine signaling in the striatum. In addition, we will briefly review the therapeutic potential of selective PDE inhibitors to treat neurological and psychiatric disorders associated with abnormal striatal function." @default.
- W2317268523 created "2016-06-24" @default.
- W2317268523 creator A5026508391 @default.
- W2317268523 creator A5034485642 @default.
- W2317268523 date "2015-01-13" @default.
- W2317268523 modified "2023-10-16" @default.
- W2317268523 title "Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders" @default.
- W2317268523 doi "https://doi.org/10.2174/1871524914666141226103421" @default.
- W2317268523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25540976" @default.
- W2317268523 hasPublicationYear "2015" @default.
- W2317268523 type Work @default.
- W2317268523 sameAs 2317268523 @default.
- W2317268523 citedByCount "19" @default.
- W2317268523 countsByYear W23172685232015 @default.
- W2317268523 countsByYear W23172685232016 @default.
- W2317268523 countsByYear W23172685232017 @default.
- W2317268523 countsByYear W23172685232018 @default.
- W2317268523 countsByYear W23172685232019 @default.
- W2317268523 countsByYear W23172685232020 @default.
- W2317268523 countsByYear W23172685232021 @default.
- W2317268523 countsByYear W23172685232022 @default.
- W2317268523 crossrefType "journal-article" @default.
- W2317268523 hasAuthorship W2317268523A5026508391 @default.
- W2317268523 hasAuthorship W2317268523A5034485642 @default.
- W2317268523 hasConcept C120069818 @default.
- W2317268523 hasConcept C137183658 @default.
- W2317268523 hasConcept C169760540 @default.
- W2317268523 hasConcept C181199279 @default.
- W2317268523 hasConcept C2779178603 @default.
- W2317268523 hasConcept C2780062018 @default.
- W2317268523 hasConcept C44208683 @default.
- W2317268523 hasConcept C513476851 @default.
- W2317268523 hasConcept C55493867 @default.
- W2317268523 hasConcept C62478195 @default.
- W2317268523 hasConcept C62826618 @default.
- W2317268523 hasConcept C71924100 @default.
- W2317268523 hasConcept C79418042 @default.
- W2317268523 hasConcept C86803240 @default.
- W2317268523 hasConcept C95444343 @default.
- W2317268523 hasConcept C98274493 @default.
- W2317268523 hasConceptScore W2317268523C120069818 @default.
- W2317268523 hasConceptScore W2317268523C137183658 @default.
- W2317268523 hasConceptScore W2317268523C169760540 @default.
- W2317268523 hasConceptScore W2317268523C181199279 @default.
- W2317268523 hasConceptScore W2317268523C2779178603 @default.
- W2317268523 hasConceptScore W2317268523C2780062018 @default.
- W2317268523 hasConceptScore W2317268523C44208683 @default.
- W2317268523 hasConceptScore W2317268523C513476851 @default.
- W2317268523 hasConceptScore W2317268523C55493867 @default.
- W2317268523 hasConceptScore W2317268523C62478195 @default.
- W2317268523 hasConceptScore W2317268523C62826618 @default.
- W2317268523 hasConceptScore W2317268523C71924100 @default.
- W2317268523 hasConceptScore W2317268523C79418042 @default.
- W2317268523 hasConceptScore W2317268523C86803240 @default.
- W2317268523 hasConceptScore W2317268523C95444343 @default.
- W2317268523 hasConceptScore W2317268523C98274493 @default.
- W2317268523 hasIssue "2" @default.
- W2317268523 hasLocation W23172685231 @default.
- W2317268523 hasLocation W23172685232 @default.
- W2317268523 hasOpenAccess W2317268523 @default.
- W2317268523 hasPrimaryLocation W23172685231 @default.
- W2317268523 hasRelatedWork W2008253670 @default.
- W2317268523 hasRelatedWork W2013651159 @default.
- W2317268523 hasRelatedWork W2022726524 @default.
- W2317268523 hasRelatedWork W2025791859 @default.
- W2317268523 hasRelatedWork W2054853415 @default.
- W2317268523 hasRelatedWork W2067787254 @default.
- W2317268523 hasRelatedWork W2078308586 @default.
- W2317268523 hasRelatedWork W2317268523 @default.
- W2317268523 hasRelatedWork W2904911604 @default.
- W2317268523 hasRelatedWork W3153750303 @default.
- W2317268523 hasVolume "14" @default.
- W2317268523 isParatext "false" @default.
- W2317268523 isRetracted "false" @default.
- W2317268523 magId "2317268523" @default.
- W2317268523 workType "article" @default.